Seventeen smallcap stocks have turned multibaggers since Modi 3.0's first budget, delivering over 100% returns despite a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Panacea Biotec has reached one of its milestones by recently winning the contract from UNICEF to procure 115 million doses of bivalent oral polio vaccine (bOPV) in 2025, valued at ₹127 crore ...

The small-cap stock in an exchange filing on Tuesday, December 24 said, “We are delighted to inform you that Panacea Biotec Limited has received a Letter of Award from UNICEF for supply of 115 ...

Panacea Biotec share price locked at 5 percent upper circuit on December 26 following the company received Letter Of Award (LoA) from United Nations International Children's Emergency Fund (UNICEF ...

Panacea Biotec stock opened with a gain of 5 percent to hit an intraday high of Rs 454.90 per share on the NSE. Later, it pared some of the gains to quote at Rs 445.05 apiece, up 2.72 percent at ...

Panacea Biotec has not announced any Dividend since 2018.

Panacea Biotec has received a Letter of Award from UNICEF for supply of 115 million doses of its bivalent oral polio vaccine (bOPV) worth ~USD 14.95 million (~Rs.127 Crore) in CY25. The supply of ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.